Poltreg S.A. (WSE: PTG)

Market Cap	249.96M
Revenue (ttm)	900.00K
Net Income (ttm)	-15.65M
Shares Out	4.66M
EPS (ttm)	-3.35
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	998
Open	52.80
Previous Close	53.80
Day's Range	52.00 - 53.60
52-Week Range	43.40 - 60.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 12, 2024

About Poltreg

Poltreg S.A., a biotechnology company, develops therapies for autoimmune diseases. It engages in the research and development of therapies for the treatment of type 1 diabetes in children, and multiple sclerosis. The company was incorporated in 2016 and is based in Gdansk, Poland.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2016
• Employees: 26
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: PTG

Financial Performance

In 2023, Poltreg's revenue was 1.40 million, an increase of 40.04% compared to the previous year's 999,000. Losses were -13.55 million, 588.9% more than in 2022.